These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26920352)

  • 21. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.
    Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF
    Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease.
    Knoblauch AL; Blaß BI; Steiert C; Neidert N; Puzik A; Neumann-Haefelin E; Ganner A; Kotsis F; Schäfer T; Neumann HPH; Elsheikh S; Beck J; Klingler JH
    J Neurooncol; 2024 Jul; 168(3):537-545. PubMed ID: 38647646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.
    Chan CC; Collins AB; Chew EY
    Retina; 2007 Jan; 27(1):1-7. PubMed ID: 17218907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
    Kano H; Shuto T; Iwai Y; Sheehan J; Yamamoto M; McBride HL; Sato M; Serizawa T; Yomo S; Moriki A; Kohda Y; Young B; Suzuki S; Kenai H; Duma C; Kikuchi Y; Mathieu D; Akabane A; Nagano O; Kondziolka D; Lunsford LD
    J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
    Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Wizigmann-Voos S; Breier G; Risau W; Plate KH
    Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A vitronectin M381T polymorphism increases risk of hemangioblastoma in patients with VHL gene defect.
    Huang JS; Lin CM; Cheng YC; Hung KL; Chien CC; Chen SK; Chang CJ; Chen CW; Huang CJ
    J Mol Med (Berl); 2009 Jun; 87(6):613-22. PubMed ID: 19288063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
    Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
    Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
    Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
    PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
    Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
    J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
    Wittström E; Nordling M; Andréasson S
    Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.
    Krzystolik K; Stopa M; Kuprjanowicz L; Drobek-Slowik M; Cybulski C; Jakubowska A; Gronwald J; Lubiński J; Lubiński W
    Retina; 2016 Feb; 36(2):325-34. PubMed ID: 26308528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dissection of the VHL gene in solitary capillary hemangioblastoma of the central nervous system.
    Muscarella LA; la Torre A; Faienza A; Catapano D; Bisceglia M; D'Angelo V; Parrella P; Coco M; Fini G; Tancredi A; Zelante L; Fazio VM; D'Agruma L
    J Neuropathol Exp Neurol; 2014 Jan; 73(1):50-8. PubMed ID: 24335534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
    Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P
    J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
    Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
    Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch.
    Arreola A; Payne LB; Julian MH; de Cubas AA; Daniels AB; Taylor S; Zhao H; Darden J; Bautch VL; Rathmell WK; Chappell JC
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.
    Weil RJ; Vortmeyer AO; Zhuang Z; Pack SD; Theodore N; Erickson RK; Oldfield EH
    J Neurosurg; 2002 Apr; 96(4):775-87. PubMed ID: 11990821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.